Staci Stevens
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Staci R. Stevens, MA in exercise physiology. Founder and Director of Workwell Foundation, Ripon, California, US.[1] She serves as Co-Vice President of the Board of Directors and Chair of the Membership Committee of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.[2] She served a term on the Chronic Fatigue Syndrome Advisory Committee from 2003 - 2006.[3] Stevens is one of the authors of the 2011 case definition, International Consensus Criteria.[4]
Stevens had (in her own words) a very well-controlled case of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) for greater than 20 years, which motivates her high commitment to advancing understanding of the illness and helping other patients.[5]
Boards and committees[edit | edit source]
- 2003-2006, member of the Chronic Fatigue Syndrome Advisory Committee for the Department of Health and Human Services
- 2011, member of the writing committee for the case definition, International Consensus Criteria[4]
- 2014-2018, Co-Vice President of the Board of Directors and Chair of the Membership Committee of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[2]
- 2018, member of the Quality of Life/Functional Status (CPET)/Activity Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention[6]
Talks and interviews[edit | edit source]
- 2009, Staci Steven speaking to CFSAC meeting
- 2010, Slide presentation to CFSAC
- 2011, "Effective Management of Activity Intolerance" - Staci R. Stevens, MA at the 10th International IACFSME Conference, Patient Agenda
- 2012, MECFS Alert Episode 32: Staci Stevens, Director of the Pacific Fatigue Lab
- 2012, Top 10 Things You Should Know About Post-Exertional Relapse
- 2015, Video: Post-exertional malaise: How to do more with less, Staci Stevens, Vancouver BC Canada, May 2015[7]
Research studies[edit | edit source]
- 2001, Assessment of Functional Impairment by Cardiopulmonary Exercise Testing in Patients with Chronic Fatigue Syndrome[8]
- 2001, Chronic Fatigue Syndrome, Ampligen, and Quality of Life: A Phenomenological Perspective[9] (Abstract)
- 2005, Exercise capacity and immune function in male and female patients with Chronic Fatigue Syndrome (CFS)[10]
- 2007, Legal and Scientific Considerations of the Exercise Stress Test[11]
- 2007, Diminished Cardiopulmonary Capacity During Post-Exertional Malaise[12]
- 2010, Post-exertional malaise in women with chronic fatigue syndrome[13]
- 2010, Conceptual model for physical therapist management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[14]
- 2011, Diagnostic accuracy of symptoms characterising chronic fatigue syndrome[15]
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[16] (Full Text)
- 2013, Discriminative validity of metabolic and workload measurements to identify individuals with Chronic Fatigue Syndrome[17] (Full Text)
- 2018, Editorial - Checking our blind spots: current status of research evidence summaries in ME/CFS.[18] (Introduction)
- 2018, Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[19] (Abstract)
- 2019, Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?[20] (Full text)
- 2019, Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing[21] (Full text)
See also[edit | edit source]
References[edit | edit source]
- ↑ http://www.workwellfoundation.org/about-us/
- ↑ 2.0 2.1 "Leadership of the IACFS/ME". IACFS/ME.
- ↑ https://wayback.archive-it.org/3919/20140324192954/http://www.hhs.gov/advcomcfs/meetings/minutes/sept_meeting_min.html/
- ↑ 4.0 4.1 Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A.C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
- ↑ http://www.prohealth.com/library/showarticle.cfm?libid=14310
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
- ↑ Stevens, Staci R; ME/FM Society of British Columbia (Canada) (May 24, 2015), Video: Post-exertional malaise: How to do more with less, Vancouver, BC, Canada
- ↑ J. Mark Vanness, Christopher R. Snell, Dean M. Fredrickson, David R. Strayer & Staci R. Stevens. (2001). Assessment of Functional Impairment by Cardiopulmonary Exercise Testing in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 8, Iss. 3-4, pp. 103-109. http://dx.doi.org/10.1300/J092v08n03_09
- ↑ Snell, Christopher R; Stevens, Staci R; VanNess, J Mark (2001), "Chronic Fatigue Syndrome, Ampligen, and Quality of Life: A Phenomenological Perspective", Journal of Chronic Fatigue Syndrome, 8 (3–4): 117-121, doi:10.1300/J092v08n03_11
- ↑ Snell, Christopher R; VanNess, J Mark; Strayer, David R; Stevens, Staci R (2005), "Exercise capacity and immune function in male and female patients with Chronic Fatigue Syndrome (CFS)" (PDF), In Vivo, 19: 387–390, PMID 15796202
- ↑ Margaret Ciccolella, Staci R. Stevens, Christopher R. Snell & J. Mark Vanness. (2007). Legal and Scientific Considerations of the Exercise Stress Test. Journal of Chronic Fatigue Syndrome, Vol. 14, Iss. 2, pp. 61-75. http://dx.doi.org/10.1300/J092v14n02_06
- ↑ J. Mark Vanness, Christopher R. Snell, and Staci R. Stevens. (2007). Diminished Cardiopulmonary Capacity During Post-Exertional Malaise. Journal of Chronic Fatigue Syndrome, Vol. 14, Iss. 2, pp. 77-85. http://dx.doi.org/10.1300/J092v14n02_07
- ↑ VanNess, J Mark; Stevens, Staci R; Bateman, Lucinda; Stiles, Travis L; Snell, Christopher R (January 4, 2010), "Post-exertional malaise in women with chronic fatigue syndrome", J Womens Health (Larchmt), 19 (2): 239-44, doi:10.1089/jwh.2009.1507, PMID 20095909
- ↑ Davenport, Todd E; Stevens, Staci R; VanNess, J Mark; Snell, Christopher R; Little, Tamara (March 31, 2010), "Conceptual model for physical therapist management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Physical Therapy (APTA), 90 (4): 602-614, doi:10.2522/ptj.20090047, PMID 20185614
- ↑ Davenport, Todd E; Stevens, Staci R; Baroni, Katie; VanNess, J Mark; Snell, Christopher R (January 6, 2011), "Diagnostic accuracy of symptoms characterising chronic fatigue syndrome", Disabil Rehabil, 33 (19–20): 1768–75, doi:10.3109/09638288.2010.546936, PMID 21208154
- ↑ Strayer, DR; Carter, WA; Stouch, BC; Stevens, SR; Bateman, L; Cimoch, PJ; Lapp, CW; Peterson, DL; Chronic Fatigue Syndrome AMP-516 Study Group; Mitchell, WM (2012), "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.", PLoS One, 7 (3): e31334, doi:10.1371/journal.pone.0031334, PMID 22431963
- ↑ Snell, Christopher R; Stevens, Staci R; Davenport, Todd E; VanNess, J Mark (October 31, 2013), "Discriminative Validity of Metabolic and Workload Measurements for Identifying People With Chronic Fatigue Syndrome", Physical Therapy (APTA), 93 (11): 1484-1492, doi:10.2522/ptj.20110368, PMID 23813081
- ↑ Davenport, Todd E.; Stevens, Staci R.; VanNess, J. Mark; Stevens, Jared; Snell, Christopher R. (July 17, 2018). "Checking our blind spots: current status of research evidence summaries in ME/CFS". Br J Sports Med: bjsports–2018–099553. doi:10.1136/bjsports-2018-099553. ISSN 0306-3674. PMID 30018122.
- ↑ Stevens, Staci; Snell, Chris; Stevens, Jared; Keller, Betsy; VanNess, J. Mark (2018). "Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00242. ISSN 2296-2360.
- ↑ Davenport, Todd E.; Lehnen, Mary; Stevens, Staci R.; VanNess, J. Mark; Stevens, Jared; Snell, Christopher R. (March 22, 2019). "Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?". Frontiers in Pediatrics. 7. doi:10.3389/fped.2019.00082. ISSN 2296-2360.
- ↑ Bouquet, Jerome; Li, Tony; Gardy, Jennifer L.; Kang, Xiaoying; Stevens, Staci; Stevens, Jared; VanNess, Mark; Snell, Christopher; Potts, James; Miller, Ruth R.; Morshed, Muhammad; McCabe, Mark; Parker, Shoshana; Uyaguari, Miguel; Tang, Patrick; Steiner, Theodore; Chan, Wee-Shian; De Souza, Astrid-Marie; Mattman, Andre; Patrick, David M.; Chiu, Charles Y. (March 21, 2019). "Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing". PLOS ONE. 14 (3): e0212193. doi:10.1371/journal.pone.0212193. ISSN 1932-6203. PMID 30897114.
